反応式
[C:1]([OH:13])(=[O:12])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH3:11].[CH2:14](Cl)[CH2:15]Cl.CI.[CH3:20][C:21]([OH:23])=[O:22]>C(Cl)Cl.[Zn]>[C:1]([O:13][C@H:1]([CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:14][CH3:15])[CH2:20][C:21]([OH:23])=[O:22])(=[O:12])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH3:11]参加物
7
実験手順
A solution of the compound prepared in Example 1-(2) (2.5 g, 5.68 mmol) was treated with undecanoic acid (1.16 g, 6.25 mmol) and EDC.MeI (2.08 g, 7.0 mmol) in CH2Cl2 (60 mL) and then deprotected as described in Example 1-(3) with zinc (9.3 g, 142 mmol) in AcOH (40 mL) to afford (R)-3-undecanoyloxytetradecanoic acid as a colorless oil: 1H NMR (CDCl3) δ 0.89 (t, 6 H, J=6.7 Hz), 1.0-1.75 (m, 44 H), 2.29 (m, 2 H), 2.61 (m, 2 H), 5.22 (m, 1 H).
出典と根拠
- ORDレコード
- ord-80eddb78be594d4ca0182f296bdb01e2
- 出典データセット
- uspto-grants-2002_03
- 特許番号
- US06355257B1
関連ノート
読み込み中…